RxDoctor Payments DataLook up a doctor →

Thomas Moriarity, DO

Internal Medicine · Savannah, GANPI 1669443065

Payments from drug & device makers

$4,596,934in general payments, 2019–2025

Across 1,265 payments — averaging $3633.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$1.6M
  • Modernatx, Inc.$1000K
  • Boehringer Ingelheim$699K
  • Vertex$516K
  • Organon$367K
  • Novartis$161K
  • plus $235K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Pfizer158$1,618,694
Modernatx, Inc.85$999,528
Boehringer Ingelheim60$699,468
Vertex4$515,892
Organon33$367,295
Novartis71$160,622
Alnylam Pharmaceuticals Inc.26$103,593
Astrazeneca UK Limited3$38,305
Cleerly, Inc.1$26,348
Boehringer Ingelheim International GmbH114$23,237
Janssen Research & Development, LLC3$18,725
Boehringer Ingelheim Pharma GmbH & Co.kg5$15,023
Amgen(2 entities)153$1,461
Novo Nordisk AS49$1,348
AbbVie(2 entities)54$838
Novo Nordisk57$751
GSK20$713
Lilly USA, LLC35$601
AstraZeneca(2 entities)32$576
Esperion Therapeutics, Inc.24$556
Supernus Pharmaceuticals, Inc.130$406
Johnson & Johnson20$406
Bayer13$317
Biohaven Pharmaceutical Holding Company Ltd.7$229
Merck14$213
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC10$162
La Jolla Pharmaceutical Company1$135
Gilead1$133
Teva Pharmaceuticals USA, Inc.9$128
Kowa Pharmaceuticals America, Inc.8$116
Sanofi-aventis U.S. LLC6$107
Otsuka America Pharmaceutical, Inc.5$102
Biohaven Pharmaceuticals, Inc.4$74
Amarin Pharma, Inc.4$68
Idorsia Pharmaceuticals US Inc3$62
Takeda Pharmaceuticals U.S.A., Inc.4$62
Eisai Inc.3$45
Dexcom, Inc.3$43
Boston Scientific2$40
Biogen2$38
EMD Serono, Inc.3$37
Avanir Pharmaceuticals, Inc.2$36
Exact Sciences2$33
Medtronic2$32
Lundbeck LLC2$32
Melinta Therapeutics, LLC1$29
Radius Health, Inc.2$28
Neurocrine Biosciences, Inc.1$24
Abbott1$21
Jazz Pharmaceuticals Inc.1$20
Astellas Pharma US Inc1$19
Harmony Biosciences LLC1$18
Upsher-smith Laboratories LLC1$17
Inspire Medical Systems, Inc.1$17
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)1$17
Alcon1$16
Sanofi Pasteur Inc.1$14
E.r. Squibb & Sons, L.L.C.1$13
AMAG Pharmaceuticals, Inc.1$13
Arbor Pharmaceuticals, Inc.1$13

How this compares

$4,596,934 in reported general payments places this provider in the 95th percentile of 3,311 internal medicine providers in Georgia.

See all internal medicine providers in Georgia →

Medicare billing

Part B allowed, 2024
$410,460
Medicare patients
935
Services billed
13,710

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other internal medicine in Savannah

See the full list for Georgia →

Where these figures come from

Is this you, or does something look wrong? →